Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

• Published in: Science (American Association for the Advancement of Science) Vol. 370; no. 6521; pp. 1227 - 1230
• Main Authors: Wajnberg, Ania, Amanat, Fatima, Firpo, Adolfo, Altman, Deena R., Bailey, Mark J., Mansour, Mayce, McMahon, Meagan, Meade, Philip, Mendu, Damodara Rao, Muellers, Kimberly, Stadlbauer, Daniel, Stone, Kimberly, Strohmeier, Shirin, Simon, Viviana, Aberg, Judith, Reich, David L., Krammer, Florian, Cordon-Cardo, Carlos
• Format: Journal Article
• Language: English
• Published: United States The American Association for the Advancement of Science 04.12.2020; American Association for the Advancement of Science
• Subjects: Antibodies; Antibodies, Neutralizing - blood; Antibodies, Neutralizing - immunology; Antibodies, Viral - blood; Antibodies, Viral - immunology; Antibody response; Coronaviridae; Coronaviruses; COVID-19; COVID-19 - blood; COVID-19 - immunology; Enzyme-Linked Immunosorbent Assay; Feedback (Response); Humans; IgG antibody; Immune response; Immune response (humoral); Immune system; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulin G - immunology; Infections; Longevity; Microbio; Neutralization; Neutralization Tests; Neutralizing; Pandemics; Proteins; Respiratory diseases; Robustness; SARS-CoV-2 - immunology; Severe acute respiratory syndrome coronavirus 2; Spike protein; Viral diseases; Viruses

As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains uncertain. Wajnberg et al. used a cohort of more than 30,000 infected individuals with mild to moderate COVID-19 sympt...